Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Compounders Complain They Can’t Make These Four Drugs Once They’re Deemed Biologics
Mar 09 2020
•
By
Joanne S. Eglovitch
FDA's Announcement To Shift Four Drug Substances Over To Biologics Raising Resistance • Source: Shutterstock
More from Manufacturing
More from Compliance